血糖类别的心血管风险:蒙古全国查的见解,2022-2023年
Nomuuna Batmunkh1, Khangai Enkhtugs2, Khishignemekh Munkhbat1
1Department of Endocrinology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar 14210, Mongolia.
Journal of clinical medicine
|October 16, 2024
概括
心血管疾病的风险随着糖尿病前期的增加,包括糖尿病诊断之前的禁食葡萄糖 (IFG) 损害,甚至在糖尿病诊断之前. 早期风险评估对于这些糖尿病前阶段的干预至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 心脏病学 心脏病学
- 公共卫生 公共卫生
背景情况:
- 糖尿病是心血管疾病 (CVD) 的一个主要风险因素.
- 糖尿病前期,特别是禁食葡萄糖 (IFG) 功能受损,越来越多地被认为有助于提高心血管疾病风险.
- 了解血糖状况对心血管疾病风险的影响对于预防策略至关重要.
研究的目的:
- 评估不同血糖类别的心血管疾病 (CVD) 风险:正常血糖,禁食葡萄糖受损 (IFG),新诊断的糖尿病和长期糖尿病.
- 评估蒙古大人口中血糖状况与心血管疾病风险之间的关联.
- 确定是否需要在糖尿病前期患者中早期进行心脏病风险评估.
主要方法:
- 一项涉及120,266名来自蒙古全国健康查计划 (2022-2023) 的成年人的横截面研究.
- 根据空腹血糖水平,参与者被分为正常血糖,IFG,新诊断的糖尿病和长期存在的糖尿病.
- 用世卫组织风险预测图表计算心血管疾病 (CVD) 风险,包括年龄,血压,吸烟和糖尿病状况.
主要成果:
- 观察到心血管疾病风险的显著变化跨血糖类别.
- 与正常血糖患者 (31.2%) 相比,IFG患者中度心血管疾病风险比例较高 (39.9%).
- 血糖状况,包括IFG,与中度至高心血管疾病风险 (OR:1.13;95% CI:1.09-1.18) 独立相关,即使经过对共变量进行调整.
结论:
- 该研究强调,禁食葡萄糖 (IFG) 的受损与心血管疾病 (CVD) 风险增加有关.
- 早期的心血管风险评估和干预是必要的,特别是在糖尿病前阶段的个体.
- 公共卫生战略应将血糖状况视为心血管疾病预防计划中的关键因素.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Hormones Regulating Blood Glucose
3.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K
Overview of Carbohydrate Metabolism
764
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
764
Oral Hypoglycemic Agents: Biguanides and Glitazones
178
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
178
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
163
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
163
Diabetes: Symptoms, Diagnosis, and Complications
512
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
512


